津膜科技：超纯水用终端超滤膜仍处于研发及应用测试阶段

证券之星07-17

证券之星消息，津膜科技(300334)07月16日在投资者关系平台上答复投资者关心的问题。

投资者提问：近年来国内长鑫，长江，中芯均有扩厂，且更加注重国产自主可控，请问公司产品对于这些新建半导体产能中超纯水需求是否有参与设计调试？

津膜科技回复：您好！公司膜产品在上述领域的水处理环节有应用，但收入占比低、并非近期新增业务，且市场中有同类产品；超纯水用终端超滤膜等新产品仍处于研发及应用测试阶段，目前并未形成任何收入，能否完成产业化、形成规模化销售和贡献业绩存在不确定性。感谢关注。

本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。

责任编辑：陈思雨

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2652747346?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-17 08:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652747346","market":"sh","top_or_hot":-1,"title":"津膜科技：超纯水用终端超滤膜仍处于研发及应用测试阶段","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/300334\">津膜科技</a>(300334)07月16日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：近年来国内长鑫，长江，中芯均有扩厂，且更加注重国产自主可控，请问公司产品对于这些新建半导体产能中超纯水需求是否有参与设计调试？</p><p>津膜科技回复：您好！公司膜产品在上述领域的水处理环节有应用，但收入占比低、并非近期新增业务，且市场中有同类产品；超纯水用终端超滤膜等新产品仍处于研发及应用测试阶段，目前并未形成任何收入，能否完成产业化、形成规模化销售和贡献业绩存在不确定性。感谢关注。</p><p>本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。</p><p>责任编辑：陈思雨</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>津膜科技：超纯水用终端超滤膜仍处于研发及应用测试阶段</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n津膜科技：超纯水用终端超滤膜仍处于研发及应用测试阶段\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-17 08:42 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026071700007585.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，津膜科技(300334)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：近年来国内长鑫，长江，中芯均有扩厂，且更加注重国产自主可控，请问公司产品对于这些新建半导体产能中超纯水需求是否有参与设计调试？津膜科技回复：您好！公司膜产品在上述领域的水处理环节有应用，但收入占比低、并非近期新增业务，且市场中有同类产品；超纯水用终端超滤膜等新产品仍处于研发及应用测试阶段，目前并未...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026071700007585.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0135","symbol_name":"污水处理","start_time":0,"source_url":"https://stock.stockstar.com/RB2026071700007585.shtml","article_id":"2652747346","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652747346","pubTimestamp":1784248928,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，津膜科技(300334)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：近年来国内长鑫，长江，中芯均有扩厂，且更加注重国产自主可控，请问公司产品对于这些新建半导体产能中超纯水需求是否有参与设计调试？津膜科技回复：您好！公司膜产品在上述领域的水处理环节有应用，但收入占比低、并非近期新增业务，且市场中有同类产品；超纯水用终端超滤膜等新产品仍处于研发及应用测试阶段，目前并未形成任何收入，能否完成产业化、形成规模化销售和贡献业绩存在不确定性。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300334":"津膜科技","BK0135":"污水处理","BK0251":"专用设备","BK0028":"国家队","BK0122":"高校"},"translate_title":"Jinmu Technology: Terminal ultrafiltration membrane for ultrapure water is still in the stage of research and development and application testing","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300334":1.5},"content_text":"证券之星消息，津膜科技(300334)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：近年来国内长鑫，长江，中芯均有扩厂，且更加注重国产自主可控，请问公司产品对于这些新建半导体产能中超纯水需求是否有参与设计调试？津膜科技回复：您好！公司膜产品在上述领域的水处理环节有应用，但收入占比低、并非近期新增业务，且市场中有同类产品；超纯水用终端超滤膜等新产品仍处于研发及应用测试阶段，目前并未形成任何收入，能否完成产业化、形成规模化销售和贡献业绩存在不确定性。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2652747346","isCrawlerRequest":true}